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Abstract.  Plasmalemmal caveolae are a  membrane 
specialization that mediates transcytosis across en- 
dothelial cells and the uptake of small molecules and 
ions by both epithelial and connective tissue cells. Re- 
cent findings suggest that caveolae may, in addition, be 
involved in signal transduction. To better understand 
the molecular composition of this membrane special- 
ization, we have developed a biochemical method for 
purifying caveolae from chicken smooth muscle cells. 
Biochemical and morphological markers indicate that 
we can obtain ~1.5 mg of protein in the caveolae frac- 
tion from •100  g  of chicken gizzard.  Gel electropho- 
resis shows that there are more than 30 proteins en- 
riched in caveolae relative to the plasma membrane. 
Among these proteins are:  caveolin, a  structural mole- 
cule of the caveolae coat; multiple, glycosylphospha- 
tidylinositol-anchored membrane proteins; both G~ 
and Ga subunits of heterotrimeric GTP-binding pro- 
tein; and the Ras-related GTP-binding protein, 
RaplA/B. The method we have developed will facili- 
tate future studies on the structure and function of 
caveolae. 
T  HF.RE is increasing evidence that plasmalemmal cave- 
olae are a membrane specialization capable of seal- 
ing off from the extracellular environment to create a 
unique, membrane bound compartment at the cell surface. 
The dynamics of caveolae opening and closing is best ob- 
served in endothelial cells (46,  47),  where they appear to 
form plasmalemmal vesicles that move across the cell and 
fuse with the abluminal membrane. Each round of caveolae- 
mediated transcytosis transports a portion of  molecules from 
the blood to the tissue space without merging with other en- 
docytic pathways.  Although in other cell types the budding 
event has not been seen with the electron microscope, bio- 
chemical studies have shown (1%19) that caveolae can se- 
quester membrane bound ligands away from the extracellular 
space and facilitate their delivery to the cytoplasm of the 
cell. This process is called potocytosis (3). 
What distinguishes potocytosis from other endocytic path- 
ways  is  the  use  of  glycosylphosphatidylinositol (GPI) 1- 
anchored membrane proteins to concentrate low molecular 
weight molecules and ions in closed caveolae (22, 41). Mor- 
phological  (54)  and  biochemical  (5,  7)  methods  have 
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glycosylphosphatidylinositol;  IPG,  inositolphosphoglycans;  IP3,  1,4,5- 
trisphosphate; PI-PLC,  phosphatidylinositol specific phospholipase C. 
documented that a  variety of different cell types contain 
highly clustered arrays of GPI-anchored membrane proteins 
and that a subset of these clusters is in caveolae (43, 54). The 
cytoplasmic surface of each caveolae has a  characteristic 
striated coat that is composed of integral membrane proteins 
(35, 39). The integrity of  this coat (39), as well as the cluster- 
ing of  the GPI-anchored proteins (6, 40), is dependent on the 
presence  of cholesterol in the membrane.  Therefore,  the 
structure of caveolae is highly dependent on the lipid compo- 
sition of the membrane. 
Potocytosis may be a mechanism for delivering signaling 
molecules or ions to the cell (2, 3). An extension of this idea 
is that caveolae can sometimes store or process incoming and 
outgoing cellular messengers (1). These proposals are based 
on the finding that certain of the molecules associated with 
caveolae are known to participate either directly or indirectly 
in cell signaling. One example is caveolin, an integral mem- 
brane component of the caveolar coat (39).  The phosphory- 
lation of this protein by pp60  ~rc is tightly coupled to the 
transformation of chick embryo fibroblasts by the Rous sar- 
coma virus (13).  This suggests that abnormal cell-cell and 
cell-substratum interactions, which result in the transformed 
phenotype, may be the consequence of caveolin being phos- 
phorylated on tyrosine. GPI-anchored membrane proteins 
themselves have been implicated as the source of inositol- 
phosphoglycans (IPG) that act as second messengers for a 
variety of different  hormones (37, 38, 42). In addition, 1,4,5- 
triphosphate (IP3) sensitive calcium channels (12),  as well 
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localized to caveolae, which suggests a role for potocytosis 
in calcium signaling. Finally, non-receptor tyrosine kinases 
have been found associated with isolated GPI anchor clusters 
(48, 50) and caveolin-rich membrane fractions (43). These 
kinases are activated by the binding of antibodies to GPI- 
anchored proteins (44). 
The eventual understanding of how caveolae function in 
the  cell  will  depend on  the  development of purification 
schemes that allow investigators to obtain large quantities of 
this organelle for biochemical analysis. Recently, Sargia- 
como et al. (43) described an analytical  method for obtaining 
cave.olin-rich membrane fractions from cultured fibroblasts. 
We now report on the development of a method for purifying 
biochemical  quantities of caveolae  from chicken  gizzard 
smooth muscle ceils. In addition to being enriched in at least 
30 different proteins, these caveolae appear to be a cell sur- 
face location for small and heterotrimeric GTP-binding pro- 
teins. 
Materials and Methods 
Materials 
Triton X-100, ~mercaptoethanol, glycerin, crystalline BSA, leupeptin, so- 
dium  chloride,  sodium  azide,  potassium iodide,  sucrose,  fish  gelatin, 
EDTA,  EGTA,  MOPS,  NP-40,  soybean trypsin inhibitor, pepstatin A, 
N-ethylmaleimide, and benzamidine were purchased from Sigma Chem. 
Co.  (St.  Louis,  MO).  Ammonium chloride was  from Fisher Scientific 
Co. (Fairlawn, NJ). PMSF was from Boehringer Mannheim GmbH (Ger- 
many).  DIT  and  paraformaldehyde were  from  Fluka  Chemical  Corp. 
(Ronkonkoma, NY). SDS was from Pierce (Rockford, IL). n-Octyl-fl-D- 
glucopyranoside (octyl-glucoside) was from Calbiochem Co.  (La Jolla, 
CA). Monoclonal anti-DNP IgG was from Oxford Biomedical Research 
(Oxford, MI). Goat anti-rabbit IgG conjugated to gold (10 run) was from 
Biocell Research Laboratories (Ted Pella, Redding, CA). 125I-conjugated 
to goat anti-rabbit IgG and goat anti-mouse IgG and  [125I]streptavidin 
were from Amersham Corp.  (Arlington Heights, IL).  [a-32p]GTP  was 
from DuPont New England Nuclear Co. (Boston, MA). Biotinylated horse 
anti-mouse serum and horse serum were from Vector Labs. (Burlingame, 
CA). Alkaline phosphatase-conjugated goat anti-rabbit or goat anti-mouse 
IgG and BCIP/NBT alkaline phosphatase substrate system were from Bio- 
Rad Labs. (Hercules, CA). Phosphatidylinositol specific phospholipase C 
(PI-PLC) was from ICN Biochemicals Co. (Cleveland, OH). Monoclonal 
anti-caveolin IgG (20B) was kindly provided by Dr. J. Glenney (University 
of Kentucky, Lexington). The following antisera against beterotrimeric G 
proteins were prepared as previously described (29):  anti-Gas  (584), anti- 
Gail/ai2  (BO87),  anti-G~B  (C-260),  and  anti-Gfl  (B-600).  An  affinity 
purified anti-peptide antibody against RaplA/B was prepared as previously 
described (4, 25). An antibody that recognizes a common epitope [Cross 
Reacting Determinant (CRD)] exposed  on all GPI-anchored membrane pro- 
teins after release from the membrane by PI-PLC was prepared as previ- 
ously described (15). 
Buffers used were prepared according to the following formulas: (buffer 
A) 50 mM MOPS, 150 mM NaC1, 5 mM EDTA, 5 mM EGTA, 0.05%  so- 
dium azide, pH 7.1, 1 mM DTT,  10/~M leupeptin, 0.5 mM benzamidine, 
10/zg/ml soybean trypsin inhibitor,  1 /zg/ml  pepstatin A,  1 mM PMSF. 
(buffer B) 0.25 M sucrose, 10 mM Tris, 5 mM EDTA, 5 mM EGTA, 0.05% 
sodium azide, pH 7.1, 1 mM DTT,  10/zM leupeptin, 0.5 mM benzamidine, 
10 #g/ml soybean trypsin inhibitor,  1 /~g/ml pepstatin A,  1 mM PMSF. 
(buffer C) 2 M sucrose, 10 mM Tris, 5 mM EDTA, 5 mM EGTA, 0.05% 
sodium azide, pH 7.1, 1 mM DTT,  10/zM leupeptin, 0.5 mM benzamidine, 
10/zg/ml soybean trypsin inhibitor,  1 /~g/ml pepstatin A,  1 mM PMSF. 
(buffer D) 50 mM MOPS, 300 mM NaC1,  5 mM EDTA, 5 mM EGTA, 
0.05%  sodium azide, pH 7.1, 1 mM DTT,  10/zM leupeptin, 0.5 mM ben- 
zamidine, 10/zg/ml soybean trypsin inhibitor, 1/~g/ml pepstatin A, 1 mM 
PMSF. (buffer E) 2.3 mM NaH2PO4-H20,  7.7 mM Na2HPO4-7H20,  150 
mM NaC1, 2 mM MgCI2, pH 7.4.  (buffer F) buffer E plus 2 mg/ml heat- 
denatured BSA (80°C,  3 min). (buffer G) buffer E plus 0.2 mg/ml heat- 
denatured BSA. (buffer H) buffer E plus 2 mg/ml heat-denatured BSA and 
2 % horse serum.  (buffer I) 50 mM Tris, pH 8.0, 2  mM CaCI2,  80 mM 
NaCI. (buffer J) buffer I plus 5% nonfat dry milk, 0.2%  (vol/vol) NP-40, 
0.02 % sodium azide. (buffer K) 50 mM Tris, pH 7.5, 300 mM NaCI. (buffer 
L) buffer K plus 3% fish gelatin. (buffer M) buffer K plus 1% fish gelatin. 
(buffer N) 50 mM Tris-HC1,  0.3% Tween 20, 5 m_M MgC12, 1 m_M EGTA, 
pH 7.5. (buffer O) 100 mM phosphate buffer, pH 7.4.  (buffer P) buffer O 
containing 0.1% BSA, 0.02%  sodium azide, and 0.05%  saponin. (buffer Q) 
buffer O containing 0.1% BSA. 
Methods 
Purification  of Caveolae. The purification scheme is shown in Fig.  1. All 
steps were carded out at 4°C. A plasma membrane fraction from chicken 
gizzard was prepared by a modification of  the methods reported by Lucchesi 
et al. (28) and Hubbard et al. (16). One hundred grams of gizzard was ex- 
cised, trimmed of connective tissue, and minced in 0.25 L of buffer A in 
a Waxing blender for 30 s. The minced tissue was further homogenized with 
2 x  30 s in a Waring blender in a total of 1 L of  buffer A. Finally the sample 
was homogenized in a polytron homogenizer (Brinkman Instruments Inc., 
Westbury, NY) for 2 x  30 s at 27,000 rpm. The crude homogenate was cen- 
trifuged for 20 rain at 5,000 g to obtain the Starting Material.  This was 
filtered through four layers of gauze before being used to prepare cave~lae. 
A small portion of the starting material was centrifuged at 100,000 g for 
1 h and designated as the total membrane fraction (see Fig. 5). The remain- 
ing starting material was centrifuged for 10 rain at 10,000 g to remove any 
aggregated material  (Pellet A).  Supernatant  A  was  filtered through  12 
layers of gauze, adjusted to 1 M KC1 and stirred for 30 rain. The mixture 
was centrifuged for 90 min at 30000 g. Pellet B was resuspended in buffer 
B by 10 up-and-down strokes of a tight-fitting dounce homogenizer. Two 
volumes of buffer C were added to the homogenate (final concentration of 
sucrose 1.42 M) and 35-mi aliquots were added to each centrifuge tube, 
Each sample was overlaid with 2 mi buffer B (sucrose concentration, 0.25 
M) and centrifuged for 60 rain at 82,000 g in a Beckman SW 28 rotor at 
4°C. The .25/1.4  M  interface (Membrane 1) was collected with a blunt- 
tipped Pasteur pipette and resuspended in buffer A by 10 strokes of a tight- 
fitting dounce homogenizer. This suspension was mixed with an equal vol- 
ume of  4 M KI (freshly prepared in buffer A) and stirred for 30 min. 36-ml 
aliquots of the sample were added to centrifuge tubes and centrifuged for 
60 rain at 100,000  g in a Beckman SW 28 rotor. A brownish, membrane 
pellicle formed at the top of 2 M K1 (Membrane H), which was collected 
with a blunt-tipped Pasteur pipette and resuspended by 10 strokes of the 
tight dounce homogenizer in buffer D and stored at 4°C. 
Membrane H, which corresponded to the plasma membrane fraction, 
was mixed with an equal volume of 2.5 M sucrose to a final concentration 
of 42%. 4-ml aliquots of the sample (7-10 rag proteins) were added to cen- 
trifuge tubes, and then overlaid with 8 ml of 25% sucrose followed by 5 ml 
of 15% sucrose. The samples were then centrifuged for 2 h at 100,000  g. 
A cloudy material accumulated at the interface between both the 15-25% 
and the 25-42 % sucrose layers. The 15-25 % sucrose interface plus the 25 % 
sucrose fraction were pooled, diluted in two times volume of buffer D and 
concentrated by centrifuging onto 42% sucrose cushion for 1 h at 100,000 g. 
The pellicle on the cushion (Membrane III) was resuspended by 10 strokes 
of a tight-fitting dounce homogenizer in buffer D. 
Membrane II1 was adjusted to a protein concentration of 4-5 mg/ml with 
buffer D, with equal volume of 1% Triton X-100 (final Triton concentration 
0.5% in buffer D) and incubated for 30 rain with constant rocking. A su- 
crose step gradient was prepared using 0.5% Triton X-100 in buffer D that 
consisted of 1.5 ml of 42%  sucrose, 3 ml 25%  sucrose, and 3.5 ml  15% 
sucrose. Two ml of Triton X-100 treated Membrane III was layered on the 
top of the sucrose gradient and centrifuged for 2  h  at  100,000  g.  The 
15-25% sucrose interface (Membrane/V) was collected and washed with 
0.1 M sodium carbonate before centrifuging for 1 h at 100,000 g onto a 42 % 
sucrose cushion. The pellicle on the cushion was collected, resuspended in 
buffer A, and stored at  -80°C. This fraction was designated caveolae. 
Radioimmunoassay.  After protein measurement, samples were first dis- 
solved in 60 mM octyi-glucoside in water, and then diluted to desired con- 
centration in water. Aliquots of the sample (10 ng) were placed in individual 
wells of an Immuno 2, 96-well plate (Dynatech Lab, Inc., Chanfilly, VA) and 
air-dried overnight. The wells were washed three times with buffer E, and 
then incubated in the presence of buffer F for 1 h at 37°C. The wells were 
washed an additional three times with buffer G before adding 50/zl of the 
anti-caveolin IgG (2/~g/ml in buffer H) to the wells and incubating for 1 h 
at 37°C. Each well was washed seven times with buffer G before adding 
50/~1 of biotinylated, horse anti-mouse IgG (2/~g/mi in buffer H) and in- 
cubating for 1 h at 37°C. The wells were washed seven times with buffer 
G before 50/~1 of [12SI]streptavidin (2/~Ci/ml in buffer F, preadsorbed with 
Dowex resin to remove free 12sI; Sp. Act. =  20-40 #Ci/#g) was added to 
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The wells were washed a final seven times with buffer G before being placed 
into a 12 x  75 mm tube and counted in a Packard Cobra H Gamma counter 
(Packard Ins. Co., Meriden, CT). 
Electrophoresis and lmmunoblot. Most of the samples were dissolved 
in sample buffer (23)  and heated for 3 min at 100°C before being loaded 
onto gels. Samples for heterotfimeric G protein analysis were prepared by 
a modification of  the method of Sternweis and Robinshaw (49). Protein sam- 
pies (20 td) were mixed with 5 ttl of 10% SDS/1 mM DTT, followed by heat- 
ing for 5 min at 100°C. The samples were then cooled to room temperature. 
A 5-/~1 aliquot of  0.3 M NEM (N-ethylmaleimide) was added to each sample 
and incubated for 10 min at room temperature. A 10-t~l aliquot of4x SDS 
sample buffer was then added to the samples and heated for 3 min at 100°C 
before loading on gels. 
Proteins were separated by SDS-PAGE using the method of Laemmli 
(23). Proteins separated on the indicated percent gels were electrophoreti- 
tally transferred to nitrocellulose membrane (pore size, 0.45  ttm) by the 
method of Towbin (51). Transfer was performed at a  100 V for 60 min at 
4°C using a solution containing 20% methanol, 0.025  M Tris, and 0.192 
M glycine (pH 8.5)  as the electrode buffer. 
[tZSl] lgG Blots. Nitrocellulose membranes were rinsed briefly with 
buffer I and incubated with buffer J for 1 h at room temperature. They were 
then  incubated  with  the  indicated  concentration  of primary  antibody 
(diluted in buffer J) for 1 h at room temperature or overnight at 4°C. The 
blots were washed three times for 15 min in buffer J, and then incubated 
with either 125I-conjugated goat anti-mouse IgG or goat anti-rabbit IgG at 
5  ×  105 cpm/mi (sp. act., 20 tzCi/t~g of protein) in buffer J for 1 h at room 
temperature. The blots were washed three times for  15 min in buffer J, 
rinsed two times in buffer I, and then washed two times for 10 min in buffer 
I.  Antibody  binding  was  visualized  by  autoradiography  using  Kodak 
X-OMAT AR film. 
Alkaline Phesphatase  BCIP/NBT Blots. Nitrocellulose membranes were 
rinsed briefly with buffer K and incubated with buffer L  for 1 h at room 
temperature. The blots were then incubated with the indicated concentration 
of primary antibody (diluted in buffer M) for 1 h at room temperature or 
overnight at 4°C. The blots were washed three times for 5 min in buffer M, 
and then incubated with alkaline phosphatase-conjugated to either goat 
anti-mouse IgG  (1:2,000  dilution in buffer M) or goat anti-rabbit IgG 
(1:2,000  dilution in buffer M) for 2 h at room temperature. The blots were 
washed three times for 5 min in buffer K, and then processed to visualize 
the bands using the BCIP/NBT alkaline phosphatase substrate system. 
[tx-52P]GTP Binding. [c~-32p]GTP binding was carded out according to 
the method of Lapetina and Reep (24). The nitrocellulose containing trans- 
ferred proteins was rinsed briefly in buffer N. The nitrocellulose was then 
incubated for 90 min at room temperature with [a-32P]GTP in buffer N 
(1 #Ci/ml; specific activity, 3,000 Ci/mmol) in the absence or presence of 
1 /zM GTP. The blots were rinsed with several changes of buffer N over 
l'x,2 h and air-dried. [et-32p]GTP binding was visualized by autoradiogra- 
phy using Kodak X-OMAT AR film. 
PI-PLC Treatment. PI-PLC treatment was carried out using a modifica- 
tion of a method of Lisanti et al. (26). Membrane samples were dissolved 
in 60 mM octyl-glucoside. The samples were then incubated in the presence 
or absence of PI-PLC (4 U/ml) for 1 h at 37°C. The reactions were stopped 
by addition of Laemmli sample buffer and boiled for 3 min. The samples 
were subjected to SDS-PAGE and transferred to nitrocellulose paper. 
lmmuno-Gold Labeling of Thin Sections. Fresh chicken gizzard was 
fixed overnight in 3 % (wt/vol) paraformaidehyde in buffer O containing 3 
mM trinitrophenol, 4  mM KCI, and 2  mM MgCI2.  Vibratome sections 
(60-80/~m thick) of the fixed chicken gizzard were prepared and washed 
in buffer O containing 100 mM NI-I4C1 for 30 min. The sections were then 
rinsed twice with buffer O and incubated in buffer P for 1-3 h at room tem- 
perature. Primary antibodies, mouse monoclonal anti-caveolin IgG (desig- 
nated 20B), and irrelevant mouse monoclonal IgG (designated 2001) were 
diluted in buffer P to a final concentration of 30 t~g/ml. Groups of 6-8 sec- 
tions were incubated overnight with each of the primary antibodies. This 
was followed by an 8-h incubation in the presence of 25  /~g/ml of goat 
anti-mouse IgG conjugated to DNP in buffer P. Sections were washed after 
each incubation three times for 10 min each in buffer P. After a final wash, 
sections were rinsed twice in buffer O, fixed with 1% glutaraldehyde for 2 h 
in buffer O, washed with buffer O containing 100 mM NH4C1 for 30 rain, 
and rinsed twice in buffer O. Tissue sections were post fixed with 1% os- 
mium tetroxide in buffer O for 2 h, dehydrated, embedded in Epon, sec- 
tioned, and processed to localize DNP groups by immunogold labeling as 
previously described (34). 
lmmuno-Gold Labeling of Fractions. Samples from purified fractions 
were mixed with an equal volume of 120 mM octyl-glucoside for 10 min 
on ice without vortexing to dissociate aggregates. This was followed by fixa- 
tion with 3% paraformaldehyde in buffer O for 10 min. The fixed samples 
(2-3 #1) were air-dried onto carbon-coated grids. The grids were washed 
in buffer O followed by incubation with 100 mM NI-LtC1 (in buffer O) for 
30 min and buffer Q for 30 min. All the antibodies were diluted in buffer 
Q.  The grids were incubated 30 rain each with primary antibodies (20 
#g/ml)  followed by  50  /zg/ml  of either  goat  anti-mouse IgG  or  goat 
anti-rabbit  IgG  and  finally  a  1:30  dilution  of gold-conjugated  rabbit 
anti-goat IgG. The grids were washed after each incubation three times for 
30 rain in buffer Q. After a final wash, grids were rinsed twice in buffer 
O, post fixed with 1% osmium tetroxide in buffer O for 10 min and finally 
stained sequentially for 10 rain each with 1% tannic acid, 4% uranyl ace- 
tate, and 2% lead citrate. 
Other Methods. SDS-PAGE was carried out according to the method of 
Laemmli (23). 
Protein was determined according to Lowry et al. (27) using BSA as a 
standard. 
To measure galaetosyltransferase, 10 t~g of  the indicated membrane frac- 
tion was incubated in the presence of 25 mM MnC12, 2.5 mM mercap- 
toethanol, 0.08 mg/ml [3H]UDP galactose (sp. act.  =  17.2 Ci/mM), 10 mM 
Hepes-NaOH, pH 7.0 in the absence or presence of 66 mM N-acetylglu- 
cosamine at 37°C for 1 h. The reaction was terminated with the addition 
of 0.3 M  EDTA. The product (N-acetyl-lactosamina) was separated on a 
l-cm column of Dowex-2-C1. 
The percent of the cell surface occupied by caveolae was determined by: 
measuring the average diameter of a caveola (75 inn) and using this value 
to calculate the membrane circumference  ofa caveola; counting the number 
of  caveolae per linear length of membrane and multiplying this by the caveo- 
lar membrane circumference; and dividing total caveolar membrane cir- 
cumference by the total linear surface counted plus the total caveolar mem- 
brane circumference. 
Results 
Characterization of  Purified Caveolae 
Caveolin is the only known protein marker for caveolae (39). 
Immunogold labeling has shown that at the cell surface this 
protein is found exclusively in caveolae (39).  Since caveolin 
is also found randomly distributed in Golgi membranes (10, 
21, 39), our strategy was to prepare plasma membranes from 
a  tissue  source  that  was  rich  in  caveolae  and  track  the 
purification of the  organelle  with  anti-caveolin  IgG.  We 
chose chicken gizzard smooth muscle cells because they 
have abundant caveolae (Fig. 2 A). Immunogold labeling of 
these cells with the same anti-caveolin IgG that was subse- 
quently used to monitor purification showed that most of the 
gold labeling was confined to caveolae (Fig. 2, B and C). We 
used the typical flask shaped morphology of the caveolar 
membrane to determine that caveolae represent ~18 % of  the 
total surface membrane in these cells. Most likely this is an 
underestimate because  cells  contain  many  uninvaginated 
caveolae that cannot be detected by thin section electron mi- 
croscopy (39). 
We developed a purification protocol that requires three 
steps (Fig. 1): preparation of plasma membranes stripped of 
peripheral membrane proteins (Membrane II); enrichment 
for  light plasma  membranes  on  a  sucrose  step  gradient 
(Membrane M); and treatment of light plasma membranes 
with Triton X-100 followed by separation of soluble from in- 
soluble material on a sucrose gradient (Membrane IV). We 
measured the specific activity of caveolin in each fraction 
using a radioimmune assay for bound anti-caveolin IgG. The 
specific activity (A) and the protein profile (B) of the various 
fractions obtained in a typical purification run is shown in 
Figs. 3 and 4. The starting material had significant activity, 
but  when  we  separated  the  plasma  membrane  from the 
cytosol, most of  this activity fractionated with the membrane 
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Figure 1. Diagrammatic representation of the protocol used to pu- 
rify caveolae from chicken gizzard smooth muscle. 
(data not shown). Fig. 3 shows that when Membrane II was 
loaded  onto  a  sucrose  Step  gradient  and  centrifuged  at 
100,000 g for 2 h, the membranes at the 15%/25% interface 
had the highest caveolin specific activity. The 25 % fraction 
had nearly the same activity, but the other fractions were 
quite low. We pooled the two fractions with the highest activ- 
ity, treated them with 0.5% Triton X-100 (2-3 mg of protein 
in each treatment)and loaded the material onto a second su- 
crose step gradient (Fig. 4). The 15 %/25 % interface in this 
gradient had the highest activity, with a 1.8-fold increase over 
the Membrane III. Very little material was recovered in the 
denser fractions (data not shown). We washed the 15 %/25 % 
interface with carbonate and designated it the caveolae frac- 
tion. From 100 g wet weight of tissue, we obtained 1.5 mg 
of protein in the caveolae fraction. This fraction contained 
1-5 % of the caveolin present in the starting material. 
The above assay indicated that, compared to the plasma 
membrane fraction, there was m5-fold enrichment in caveo- 
lin in the caveolae fraction. To further assess the purity of 
the caveolae preparation,  we analyzed four different frac- 
tions by both polyacrylamide gel electrophoresis (Fig. 5 A) 
and immunoblotting using anti-caveolin IgG (Fig. 5 B). We 
could identify at least 30 different bands that copurified with 
caveolae. The most prominent proteins are indicated by the 
arrowheads and caveolin by the arrow (Fig. 5 A). By immu- 
noblotting (Fig. 5 B), three caveolin-specifie bands (appar- 
ent MI~ 22,000, 24,000, and *300,000) were most intense 
in the caveolae fraction. The high molecular weight band 
corresponds to a polymer of caveolin (14) while the two low 
molecular weight hands are isoforms of monomeric caveo- 
lin. Scanning densitometry of the caveolin-speeific bands in 
the immunoblots indicated that caveolin was enriched ~5- 
fold in the caveolae fraction relative to the plasma membrane 
and ,~200-fold relative to the whole tissue starting material 
(Fig.  1). 
Another test of the purification scheme is to show that 
marker proteins for other compartments are excluded from 
the caveolae fraction.  Fig.  5 A  documents that multiple, 
Coomassie blue positive bands were excluded as caveolae 
were purified. The pattern also indicates that many of the 
proteins in the plasma membrane were not present in the cav- 
eolae fraction (compare plasma membrane lane with caveo- 
lae lane). We also measured the activity of galactosyltrans- 
ferase, a marker for Golgi membranes. The activity in pellet 
B was 22,747 cpm/min/mg of protein, which was compara- 
ble to the activity of a control Golgi fraction isolated from 
rat liver (17,993 cpm/min/mg). By contrast, the activity in 
the caveolae fraction was not above background (1,609 cpm/ 
min/mg of protein).  Therefore, Golgi membranes did not 
contaminate the caveolae fraction. Finally, we used immu- 
noblotting to measure the concentration of the cytoplasmic 
protein, annexin VI. This protein was excluded from caveo- 
lae (data not shown). 
GPI-anchored membrane proteins are another marker for 
caveolae. Immunogold electron microscopy has shown that 
nearly every caveola is associated with a  cluster of GPI- 
anchored proteins. On the other hand, the caveolae-associ- 
ated clusters only represent *18%  of the total number of 
GPI clusters on the cell surface (54).  We used a polyclonal 
antibody  that  recognizes  the  cross-reacting  determinant 
(CRD) epitope exposed when GPI-anchored proteins are re- 
leased from membranes by PI-PLC (15) to determine if GPI- 
anchored proteins  were enriched in the caveolae fraction 
(Fig. 6, A and B). Immunoblots with this antibody detected 
at least nine different GPI-anchored membrane proteins that 
were highly enriched (Fig. 6, A and B). When we quantified 
the more intense bands by scanning densitometry we found 
that these GPI proteins were enriched 13-18-fold in the cav- 
eolae fraction relative to the plasma membrane. 
We next used whole mount electron microscopy and im- 
munogold cytochemistry to characterize the morphology of 
the membranes in the caveolae fraction (Fig. 7). Samples of 
the fraction were fixed, dried down onto the surface of a 
formvar-coated grid, and positively stained with heavy met- 
als (Fig. 7 A). These fractions typically  contained numerous, 
cup-shaped pieces of membrane.  At higher magnifcation 
(Fig. 7 A, inset), these cups appeared to be partially deco- 
rated by a striated coat. We also saw smaller pieces of mem- 
brane interspersed between the cup profiles. These appeared 
to be fragments of caveolae because they contained remnants 
of the coat material and were positive for anti-caveolin IgG 
binding by immunogold cytochemistry (Fig. 7 B). Nearly all 
of the membrane fragments, plus the cup-shaped segments, 
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visualization  of  chicken smooth 
muscle cells that were either 
unprocessed (A) or processed 
(B and C) to localize caveolin 
by immunogold  cytochemistry. 
Fresh chicken gizzard was ei- 
ther  fixed directly  and  em- 
bedded  for  electron micros- 
copy (A) or fixed  and processed 
to localize caveolin using ei- 
ther a monoclonal anti-cave- 
olin IgG (B) or an irrelevant 
monoclonal IgG  (C)  as  de- 
scribed. Arrowheads indicate 
caveolae. Bar, 0.5 tzm. 
decorated with anti-caveolin IgG. A high magnification view 
shows how the gold was often associated with the striated 
coat (Fig. 7 B, inset). We did not see any gold labeling when 
an irrelevant monoclonal IgG was substituted for monoclo- 
nal anti-caveolin IgG (Fig. 7  C). 
GTP-binding Proteins Are Enriched in Caveolae 
Sargiacomo et al. (43) recently reported that both small and 
heterotrimeric GTP-binding proteins coenrich with caveolin 
in  Triton  X-100  insoluble,  membrane  fractions prepared 
from tissue culture cells. We used specific antibodies to see 
if any of these regulatory proteins were also associated with 
smooth muscle caveolae. We used mono-specific peptide an- 
tibodies against various GTP-binding proteins to immuno- 
blot the indicated fractions. Fig. 8 shows that both G~s (Fig. 
8 A) and G~i3 (Fig. 8 B) are enriched in caveolae. Scanning 
densitometer reading of the blots indicated that the specific 
blotting activity of G~s was increased eightfold compared to 
plasma  membranes while G~i3 was  increased sixfold. An 
antibody that  recognizes  both  G~1  and  God2 showed that 
these subunits were also enriched ('~3-fold) in the caveolae 
fraction (Fig.  9  A).  When  we used this  antibody to  im- 
munogold label the caveolae fraction (Fig. 9 B), many of the 
caveolae profiles  were  heavily decorated  with gold.  Im- 
munogold labeling was not seen when a preimmune IgG was 
substituted for the anti-G~il/G~ IgG (data not shown). 
In contrast to the G~ subunits, the specific blotting activ- 
ity of the Ga subunit indicated that this subunit was no more 
concentrated in caveolae than in the starting material (com- 
pare starting material with caveolae, Fig. 10 A) even though 
there was some enrichment in the plasma membrane frac- 
tion. Immunoblot analysis of each fraction obtained during 
the purification showed that Triton X-100 removed Ga from 
the Membrane HI fraction (data not shown). Therefore, we 
used immunogold electron microscopy to determine if Ga 
was present in caveolae before detergent treatment (Fig.  10, 
B, C, and D). The light membrane fraction obtained before 
detergent treatment (Membrane HI, Fig.  10  C) had many 
cup-shaped membrane profiles that decorated with the anti- 
Ga IgG gold probe  (arrows, Fig.  10  C).  By contrast,  we 
found substantially less gold associated with similar appear- 
ing pieces  of membrane in the detergent-treated fraction 
(Membrane IV, Fig. 10 D). We verified that the labeled seg- 
ments  of membrane  in  Membrane  HI  were  caveolae by 
colocalizing both caveolin (large gold, Fig.  10 B) and Ga 
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of caveolin using a radioimmune  assay as described.  The 15/25% 
interface and the 25 % fraction were pooled and designated  Mem- 
brane HI. 
(small  gold,  Fig.  10 B)  to the same pieces  of membrane. 
Therefore,  caveolae  appear  to  contain  both  G~  and  Ga 
subunits of the heterotrimeric GTP-binding proteins but that 
only G~ is detergent resistant. 
We  also  found  that  several  small  GTP-binding  proteins 
were enriched in the caveolae fraction (Fig.  11,  A  and B). 
[u-~:P]GTP binding to proteins transferred to nitrocellulose 
revealed two prominent bands that were increased  '~2-fold 
in density  compared to plasma membranes.  In an effort to 
identify other GTP-binding proteins, we used a peptide anti- 
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Figure 4. The specific activity of caveolin (,4) and the protein distri- 
bution (B) in fractions obtained from the second sucrose gradient. 
Membrane III was adjusted to a protein concentration of 4-5 mg/ml 
with buffer F, adjusted to 0.5 % Triton X-100, and incubated for 30 
min, all at 4"C. The sample was then loaded on the top of a sucrose 
step gradient and centrifuged at 100,000 g for 2 h at 4°C. The gra- 
dientt was divided into four  fractions:  7%;  the 7/15% interface; 
15%; and the 15/25% interface.  Each fraction was assayed for the 
presence of caveolin using a radioimmune  assay as described.  The 
15/25%  interface  was designated  Membrane  IV. 
body that recognizes RaplA/B to label the caveolae fraction 
by  both  immunoblot  (Fig.  11  B)  and  immunogold  (Fig. 
11  C).  This  small GTP-binding  protein was enriched  '~2- 
fold in caveolae.  Moreover, antibody-specific  gold particles 
sparsely  labeled caveolae (Fig.  11  C). 
Discussion 
Caveolae have remained a relatively obscure membrane spe- 
The Journal of Cell Biology,  Volume  126,  1994  132 Figure 5. Polyacrylamide gel electrophoresis (,4) and anti-caveolin 
IgG immunoblotting (B) of different fractions obtained during the 
purification  of caveolae.  (A) Samples of the indicated  fractions (75 
#g per lane) were loaded on 6-15 % gradient gels, separated by elec- 
trophoresis and stained with Coomassie blue as described.  The ar- 
row heads indicate proteins that are enriched relative to the plasma 
membrane. The arrow marks the position of caveolin. The * marks 
a protein band that appears to be more abundant in caveolae than 
caveolin.  (B) Samples  of the indicated  fractions (5 #g per lane) 
were loaded on gels, separated by electrophoresis  (11% gel) and 
transferred  to nitrocellulose  for blotting with anti-caveolin IgG (15 
/zg/ml),  Anti-caveolin  was  detected  using  an  125I-labeled goat 
anti-mouse IgG. The arrow indicates  the caveolin band, 
Figure 6. Purified caveolae are enriched in multiple  GPI anchored 
membrane proteins.  Samples (10/~g) of  the indicated fractions were 
solubilized in 60 mM octyl-glucoside  and incubated in the presence 
(+) or absence (-) of PI-PLC for 1 h at 37°C.  Each sample was 
then separated  on an 11% gel by electrophoresis  and immunoblot- 
ted with rabbit anti-CRD IgG (serum) using 125I-goat  anti-rabbit 
IgG as described.  An overnite  (A) and  a  3-d  (B)  exposure  are 
shown. 
cialization since their identification as a flask-shaped invagi- 
nation on the surface of epithelial (53) and endothelial cells 
(32) nearly 40 years ago. A  full scale investigation into the 
structure and function of caveolae could not proceed until 
there was a  method available for obtaining large quantities 
of the organdie. Two advances have now made this possible: 
the identification of a resident, integral membrane protein of 
caveolae called caveolin  (39),  and the discovery that each 
caveola contains a cluster of GPI-anchored membrane pro- 
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tron microscopic visualization 
of  untreated, purified caveolae 
(A)  or  purified  caveolae la- 
beled by immunogold with ei- 
ther anti-caveolin IgG (B) or 
irrelevant IgG  (C).  Samples 
of Membrane IV were briefly 
treated  with  octyl-glucoside 
on  ice,  fixed,  and  air-dried 
onto  grids.  The  grids  were 
then either viewed directly (.4) 
or processed to localize anti- 
caveolin IgG binding sites (B) 
or non-immune IgG binding 
sites (C). Bar, 0.3/~m (inset, 
0.2 ~tm). 
teins (41).  We have used the relative enrichment of these 
markers as a guide for purification. 
In any purification scheme a question always arises about 
the purity of the final preparation. A linear measure of the 
plasma membrane indicates that caveolae make up •18  % of 
the surface of chicken gizzard smooth muscle cells. If all of 
the non-caveolar membrane was removed from the plasma 
membrane, then a 5.5-fold enrichment for the caveolae seg- 
ment is all that is needed for a  complete purification. We 
used  both  a  radioimmune  assay  for caveolin  and  whole 
mount electron microscopy to monitor purification. Anti- 
caveolin IgG was useful for monitoring caveolae behavior 
during the fractionation, but we could not use this marker 
to determine purity because we do not know the specific con- 
centration of caveolin in each caveolae or whether all caveo- 
lae have caveolin. Therefore, we used electron microscopy 
to examine the fractions with the highest caveolin specific ac- 
tivity and found that the principal membrane component had 
the  morphological  characteristics  of caveolae.  Moreover, 
nearly all of the membrane profiles in these preparations 
decorated with  anti-caveolin IgG  gold particles  (Fig.  7). 
Therefore, these fractions contain relatively pure caveolae 
The Journal of Cell Biology, Volume  126, 1994  134 Figure 8.  Immunoblot detection of either G~s (.4) or G~ti3 (n)  in 
different fractions  obtained  during the purification of caveolae. 
Samples (5 #g) of the indicated fraction were separated by elec- 
trophoresis on 11% polyacrylamide gels and immunoblotted with 
polyclonal peptide antisera against either G~s (A) or G~i3 (B) using 
~25I-goat anti-rabbit  IgG to detect the rabbit IgG. 
even though caveolin is enriched only ~5-fold relative to the 
plasma membrane. 
In contrast to caveolin, GPI-anchored membrane proteins 
were enriched '~15-fold in the caveolae fraction. The anti- 
CRD  IgG  detected at  least  nine  bands  on  immunoblots. 
Scanning densitometry of the four most prominent bands 
showed that they were enriched from 13-18-fold. The rela- 
tive enrichment was independent of the band intensity. This 
suggests that the GPI-anchored proteins are purifying as a 
Figure  9.  Immunoblot  (A) and immunogold (B) localization of 
G~it/G,i2 in fractions obtained during the purification of caveolae. 
(A) Samples (5/~g) of  the indicated fraction were separated by elec- 
trophoresis on 11% polyacrylamide gels and immunoblotted with 
polyclonal  peptide  antisera  (1:2,000 dilution)  against G~til/Gcd2 
using 125I-goat anti-rabbit  IgG to detect the rabbit IgG. (B) The 
caveolae fraction  was  processed  for whole  mount  immunogold 
labeling with anti-G~it/G~2 antisera  (B) using an antibody sand- 
wich that  consisted of, goat  anti-rabbit  IgG  followed by gold- 
conjugated rabbit anti-goat IgG. Bar, 0.3/~m. 
unit but that there are variable amounts of the individual pro- 
teins within the unit. These findings are consistent with elec- 
tron  microscopic  studies  showing  that  caveolae  contain 
clusters of  GPI-anchored proteins composed of  multiple pro- 
tein species (54). 
An analysis of the polyacrylamide gel staining pattern for 
purified caveolae shows that they contain a complex mixture 
of  proteins. Relative to the plasma membrane, many proteins 
are enriched, some are excluded, and still others are present 
at the same concentration (compare bands present in plasma 
membrane lane with those in the caveolae lane, Fig, 5). We 
determined by immunoblot and immunogold labeling (data 
not shown) that one of the proteins in the last category is ac- 
tin (at the 45-kD marker, Fig. 5 A). Despite the harsh salt 
and detergent treatments, actin remained bound to caveolae 
throughout the purification. This association may be due to 
the presence of a high affinity, actin-binding protein in caveo- 
lae or simply be the consequence of a non-specific interac- 
tion. Nevertheless, these results point out that many of the 
proteins that are not enriched may still be legitimate compo- 
nents of the organelle. By contrast, the enriched bands prob- 
ably correspond to proteins that carry out a specific cellular 
function in caveolae. At least one of these proteins (,,  Fig. 
5 A) appeared to be more abundant than caveolin. This raises 
the possibility that caveolae contain other structural proteins 
besides caveolin. Future sequence analysis may help to de- 
termine a  function for these proteins. 
Sargiacomo et al.  (43) recently reported that heterotri- 
meric GTP-binding proteins are associated with caveolin- 
rich domains isolated from tissue culture cells. Furthermore, 
immunocytochemical studies have found that G~ colocalizes 
with caveolin in MA  104 cells (Mumby, S.  M.,  Q.  Yang, 
H. K. Hagler, A. G. Gilman, and K. H. Muntz, unpublished 
observations). We found that smooth muscle cell caveolae 
are also enriched in these proteins. Peptide antibodies that 
recognize different G~ subunits  were used to monitor the 
specific blotting  activity of each  subunit  during  caveolae 
purification. Depending on the subunit, activity was found 
to increase from 3  to 8-fold relative to the plasma mem- 
brane. Immunogold cytochemistry confirmed that both G~i~ 
and G~i2 are associated with isolated caveolae. We also suc- 
cessfully used  immunogold cytochemistry to  localize the 
other two G~ subunits to caveolae (data not shown). 
The caveolae-associated G~ most likely corresponds to a 
subset of all the G~ that is associated with the plasma mem- 
brane. This subgroup may participate in one or more signal- 
ing activities that originate in caveolae.  Interestingly, G~s 
was the least enriched G~ found in caveolin-rich domains 
from MDCK  cells (43) but the most enriched subunit in 
smooth muscle cell caveolae fractions. This suggests that the 
caveolae found in each type of cell have a unique constella- 
tion of G~ subtypes that are there to carry out cell-specific 
signaling functions. 
G  proteins  are  largely  solubilized from membranes  by 
mild detergents such as Triton X-100.  Therefore, the cav- 
eolae-associated Go  must  remain  in  caveolar membranes 
during the purification because of a tight interaction with a 
structural  component of the caveolae.  Ga, appears  not to 
hold the G~ in place because much of this complex was ex- 
tracted from partially purified caveolae by Triton X-100. We 
favor the idea that amino-terminal acylation of G~ (25) may 
control the association with caveolae. 
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and immunogold (B,  C,  and 
D) localization of Ga in frac- 
tions  obtained  during  the 
purification of caveolae.  (A) 
Samples (5  /~g) of the  indi- 
cated fraction were separated 
by  electrophoresis  on  11% 
polyacrylamide gels and im- 
munoblotted with anti-Ga an- 
tisera (diluted 1:1,000) as de- 
scribed. Membrane HI (C) or 
purified  caveolae  (D)  were 
processed  for  whole  mount 
immunogold  labeling  with 
anti-Ga  antisera  (diluted 
1:1,000) as described in Fig. 9. 
Double labeling of Membrane 
HI (B) was carried out by se- 
quential addition of antibod- 
ies, using 5-nm gold for the 
anti-Ga  antisera  and  15-nm 
gold for the anti-caveolin IgG. 
Bar, 0.3 tan (inset bar, 0.1 tan). 
There is now strong biochemical (5), morphological (40), 
and functional (6) evidence that it is the lipid environment 
of  the caveolar membrane that attracts the fatty groups on the 
GPI-anchored proteins.  Certain acylated cytoplasmic pro- 
teins may be attracted to caveolae for the same reason. Non- 
receptor, tyrosine kinases have been found associated with 
caveolin-rich membranes  (43) as  well as  clusters of GPI- 
anchored membrane proteins (7). Recently, Shenoy-Scaria et 
al.  (45,  Lublin,  D.  M.,  personal communication) showed 
that the interaction of p5(~'* and p59ry~ with GPI-anchored 
protein complexes in  Triton X-100 extracts depends on a 
thioester link to palmitate at position 3 in the amino-terminal 
sequence, Met-Gly-Cys. Myristoylation of  the glycine is also 
required. All of the G~ subunits that we detected in purified 
caveolae share with p59~ and p56  tck the Met-Gly-Cys motif 
at the NH2 terminus. Furthermore, all are palmitoylated at 
position 3  (9,  30,  33),  and,  with the exception of G~s, all 
have been found to be myristoylated at the Gly. These data 
suggest that the presence of two acylated amino acids in tan- 
dem may direct proteins to specialized membrane domains 
such as caveolae. 
This model makes the prediction that the introduction of 
tandem acyl groups into a protein would direct it to caveo- 
lae/GPI anchor complexes. We found that pp60  ~ '~ was not 
enriched in  our purified caveolae preparations.  However, 
pp60  ~ src has the sequence Met-Gly-Ser and, therefore, can 
not be tandemly acylated. Lublin and co-workers (45, Lub- 
lin, D.  M., personal communication) have now found that 
changing the Ser to a Cys causes both the tandem acylation 
of pp60  ~ s~ and the association of the kinase with GPI an- 
chor protein complexes. G,q also appears to be enriched in 
caveolar preparations  (43)  but  lacks  the  amino  terminal 
myristoylation site (Gly). Instead, this protein has tandem 
cysteine residues at positions 9 and 10 that are both acylated 
(52).  Therefore, tandem palmitoylation may work just as 
well to promote association with caveolae. 
Acylation and deacylation of G~ appears to be a dynamic 
process (30). Acylation of one or more of the tandem sites 
may be the method the cell uses to control the location of the 
subunit on surface and internal membranes. This added level 
of cellular organization in the signaling cascade could ensure 
that G proteins are spatially positioned to optimize their in- 
teraction with the appropriate receptor/effector. 
We also found evidence for the presence of small GTP- 
binding proteins in caveolae. [3:P]GTP blots showed that at 
least two proteins of 30 and 28 kD were enriched. Moreover, 
an anti-RaplA/B IgG was positive by both immunoblot and 
immunocytochemistry. RaplA/B shares extensive homology 
with  ras  protooncogenes  (36)  and  can  reverse  the  K-ras 
transformation of 3T3 cells (20). They also have been impli- 
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transport activity (8).  Recent immunocytochemical studies 
have shown that Ca  ++ ATPase is present in caveolae (11). 
Therefore, the ras related Rapl GTP-binding protein may be 
involved in regulating cytosolic calcium fluxes through cav- 
eolae. 
There are now two methods available for obtaining caveo- 
lae: the biochemical method we have developed and an ana- 
lytical method described by Sargiacomo et al.  (43).  Our 
method has two main advantages. First, the availability of 
large quantities of caveolae will facilitate the identification 
of  many of  the protein and lipid components of  the organelle. 
Second, Membrane III is quite enriched in caveolae so that 
it is possible to obtain quantities of the organelle without a 
detergent treatment step.  This is important because of the 
finding that resident proteins like Go, are removed by Tri- 
ton X-100. Undoubtedly there are many important caveolae- 
associated molecules that will be removed using a purifica- 
tion scheme that depends on detergent. Nevertheless, the two 
types of preparations are in agreement that caveolae contain 
molecules that are known to participate in diverse signaling 
pathways. These isolation procedures set the stage for deter- 
mining how caveolae function in  the  uptake  of essential 
nutrients and in the delivery of signals to the cell. 
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